Related references
Note: Only part of the references are listed.2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Jean-Philippe Collet et al.
EUROPEAN HEART JOURNAL (2021)
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherarpy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials
Daniele Giacoppo et al.
EUROPEAN HEART JOURNAL (2021)
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
Sergio Leonardi et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y12Inhibitor in Patients After Percutaneous Coronary Intervention A Systematic Review and Meta-Analysis
Michelle L. O'Donoghue et al.
CIRCULATION (2020)
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial
Byeong-Keuk Kim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials
Toshiki Kuno et al.
AMERICAN HEART JOURNAL (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
Francesco Costa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention The SMART-CHOICE Randomized Clinical Trial
Joo-Yong Hahn et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI The STOPDAPT-2 Randomized Clinical Trial
Hirotoshi Watanabe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
R. Mehran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials
Giuseppe Gargiulo et al.
EUROPEAN HEART JOURNAL (2019)
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
Anna Franzone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study
Leonardo De Luca et al.
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)
Marco Valgimigli et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2018)
Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting A Randomized Clinical Trial
Qiang Zhao et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Peter M. Bothwell et al.
LANCET (2018)
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Davide Capodanno et al.
NATURE REVIEWS CARDIOLOGY (2018)
A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?
Giuseppe Gargiulo et al.
CIRCULATION (2016)
Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement
Lesley A. Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
Marco Valgimigli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study
Gregg W. Stone et al.
LANCET (2013)
Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting A Randomized Multicenter Trial
Marco Valgimigli et al.
CIRCULATION (2012)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Impact of Bleeding on Mortality After Percutaneous Coronary Intervention Results From a Patient-Level Pooled Analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events), ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy), and HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trials
Roxana Mehran et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
